Mark Barry Abelson
Founder at Ora, Inc.
Profile
Mark Barry Abelson is the founder of Ora, Inc., which was founded in 1985.
He holds the title of Treasurer & Chief Scientific Officer at Ora, Inc. Currently, Dr. Abelson is a Senior Clinical Scientist at The Schepens Eye Research Institute, Inc. and a Professor-Ophthalmology at Harvard Medical School.
In the past, he worked as a Director at Nicox Ophthalmics, Inc.
Mark Barry Abelson active positions
| Companies | Position | Start |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 2011-03-24 |
The Schepens Eye Research Institute, Inc.
 The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA. | Corporate Officer/Principal | 2012-12-16 |
Ora, Inc.
 Ora, Inc. Medical/Nursing ServicesHealth Services Ora, Inc. provides ophthalmic services. It engages in the provision of ophthalmic services and it specializes in allergy, allergic rhinitis, dry-eye, retina, anti-infective, anti-inflammatory, glaucoma, drug delivery, and ophthalmic devices. The firm offers development services including preclinical models, clinical research and development, regulatory strategy, statistics and data management, medical writing, and marketing and advertising. The company was founded by Mark Barry Abelson in 1985 and is headquartered in Andover, MA. | Founder | 1984-12-31 |
Former positions of Mark Barry Abelson
| Companies | Position | End |
|---|---|---|
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Health Technology |
The Schepens Eye Research Institute, Inc.
The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA. | Commercial Services |
Ora, Inc.
Ora, Inc. Medical/Nursing ServicesHealth Services Ora, Inc. provides ophthalmic services. It engages in the provision of ophthalmic services and it specializes in allergy, allergic rhinitis, dry-eye, retina, anti-infective, anti-inflammatory, glaucoma, drug delivery, and ophthalmic devices. The firm offers development services including preclinical models, clinical research and development, regulatory strategy, statistics and data management, medical writing, and marketing and advertising. The company was founded by Mark Barry Abelson in 1985 and is headquartered in Andover, MA. | Health Services |
- Stock Market
- Insiders
- Mark Barry Abelson
